{"id":3470,"date":"2023-02-20T06:03:16","date_gmt":"2023-02-20T06:03:16","guid":{"rendered":"https:\/\/hdzsoft.com\/?p=3470"},"modified":"2024-07-04T09:05:03","modified_gmt":"2024-07-04T02:05:03","slug":"tiem-lucentis-nhung-dieu-can-luu-y","status":"publish","type":"post","link":"https:\/\/hdzsoft.com\/tiem-lucentis-nhung-dieu-can-luu-y\/","title":{"rendered":"TI\u00caM LUCENTIS – NH\u1eeeNG \u0110I\u1ec0U C\u1ea6N L\u01afU \u00dd"},"content":{"rendered":"
RANIBIZUMAB (LUCENTIS) l\u00e0 m\u1ed9t lo\u1ea1i thu\u1ed1c kh\u00e1ng VEGF; th\u00e0nh ph\u1ea7n l\u00e0 m\u1ed9t m\u1ea3nh c\u1ee7a kh\u00e1ng th\u1ec3 \u0111\u01a1n d\u00f2ng v\u00e0 \u0111\u00e3 \u0111\u01b0\u1ee3c ch\u1ee9ng nh\u1eadn b\u1edfi C\u1ee5c Qu\u1ea3n l\u00fd Th\u1ef1c ph\u1ea9m v\u00e0 D\u01b0\u1ee3c ph\u1ea9m Hoa K\u1ef3 (FDA) cho \u0111i\u1ec1u tr\u1ecb b\u1ec7nh ph\u00f9 ho\u00e0ng \u0111i\u1ec3m ti\u1ec3u \u0111\u01b0\u1eddng, b\u1ec7nh tho\u00e1i h\u00f3a ho\u00e0ng \u0111i\u1ec3m th\u1ec3 \u01b0\u1edbt, v\u00e0 ph\u00f9 ho\u00e0ng \u0111i\u1ec3m do c\u00e1c b\u1ec7nh l\u00fd m\u1ea1ch m\u00e1u.<\/span><\/em><\/p>\n B\u00e0i vi\u1ebft \u0111\u01b0\u1ee3c t\u01b0 v\u1ea5n chuy\u00ean m\u00f4n b\u1edfi : BSCKI D\u01b0\u01a1ng Thu Ph\u01b0\u01a1ng \u2013 Khoa \u0110\u00e1y M\u1eaft b\u1ec7nh vi\u1ec7n M\u1eaft H\u00e0 N\u1ed9i.<\/span><\/p>\n I. THU\u1ed0C LUCENTIS<\/span><\/strong><\/p>\n Thu\u1ed1c Lucentis l\u00e0 c\u00f3 th\u00e0nh ph\u1ea7n ho\u1ea1t ch\u1ea5t c\u1ee7a thu\u1ed1c l\u00e0 ranibizumab, l\u00e0 m\u1ed9t kh\u00e1ng th\u1ec3 \u0111\u01a1n d\u00f2ng gi\u00fap ch\u1ed1ng t\u1ea1o m\u1ea1ch.<\/span> B\u01a1m ti\u00eam d\u00f9ng 1 l\u1ea7n c\u00f3 ch\u1ee9a 0,05 ml dung d\u1ecbch ranibizumab g\u1ed3m c\u00f3 2 lo\u1ea1i:<\/span><\/p>\n L\u1ecd \u0111\u01a1n li\u1ec1u c\u00f3 ch\u1ee9a 0,05 ml dung d\u1ecbch ranibizumab g\u1ed3m c\u00f3 2 lo\u1ea1i:<\/span><\/p>\n <\/p>\n II. CH\u1ec8 \u0110\u1ecaNH<\/span><\/strong><\/span><\/p>\n Thu\u1ed1c ti\u00eam Lucentis (ranibizumab) \u0111\u01b0\u1ee3c ch\u1ec9 \u0111\u1ecbnh \u0111i\u1ec1u tr\u1ecb trong c\u00e1c b\u1ec7nh:<\/span><\/p>\n III. K\u1ef8 THU\u1eacT TI\u00caM THU\u1ed0C LUCENTIS<\/span><\/strong><\/p>\n IV. NH\u1eeeNG \u0110I\u1ec0U B\u1ec6NH NH\u00c2N C\u1ea6N L\u01afU \u00dd<\/span><\/strong><\/p>\n Tr\u01b0\u1edbc khi ti\u00eam:<\/span><\/strong><\/p>\n Trong khi ti\u00eam:<\/span><\/strong><\/p>\n Sau khi ti\u00eam:<\/span><\/strong><\/p>\n <\/p>\n V. NH\u1eeeNG BI\u1ebeN CH\u1ee8NG C\u00d3 TH\u1ec2 X\u1ea2Y RA<\/span><\/strong><\/p>\n VI. QUY TR\u00ccNH TI\u00caM LUCENTIS T\u1ea0I B\u1ec6NH VI\u1ec6N M\u1eaeT H\u00c0 N\u1ed8I S\u1ebc DI\u1ec4N RA NH\u01af TH\u1ebe N\u00c0O?<\/span><\/strong><\/p>\n B\u00ea\u0323nh nh\u00e2n s\u1ebd \u0111\u01b0\u1ee3c kh\u00e1m t\u1ea1i khoa kh\u00e1m b\u1ec7nh, b\u00e1c s\u0129 s\u1ebd \u0111\u00e1nh gi\u00e1 t\u00ecnh tr\u1ea1ng c\u1ee7a b\u00ea\u0323nh nh\u00e2n v\u00e0 c\u00f3 ch\u1ec9 \u0111\u1ecbnh ti\u00eam n\u1ed9i nh\u00e3n. B\u00e1c s\u0129 s\u1ebd gi\u1ea3i th\u00edch cho b\u00ea\u0323nh nh\u00e2n hi\u00ea\u0309u v\u1ec1 th\u1ee7 thu\u1eadt th\u01b0\u0323c hi\u00ea\u0323n, nguy c\u01a1 v\u00e0 l\u1ee3i \u00edch c\u1ee7a th\u1ee7 thu\u1eadt na\u0300y. B\u00ea\u0323nh nh\u00e2n c\u00f3 th\u1ec3 \u0111\u0103t c\u00e2u h\u1ecfi n\u00ea\u0301u co\u0301 th\u0103\u0301c m\u0103\u0301c \u0111\u1ec3 \u0111\u1ea3m b\u1ea3o r\u1eb1ng b\u00ea\u0323nh nh\u00e2n s\u1ebd \u0111\u01b0a ra quy\u1ebft \u0111\u1ecbnh \u0111\u00fang cho vi\u1ec7c \u0111i\u1ec1u tr\u1ecb cu\u0309a mi\u0300nh. B\u00ea\u0323nh nh\u00e2n s\u1ebd \u0111\u01b0\u1ee3c y\u00eau c\u1ea7u k\u00fd phi\u1ebfu ch\u1ea5p nh\u1eadn tr\u01b0\u1edbc khi ch\u00fang t\u00f4i th\u1ef1c hi\u1ec7n th\u1ee7 thu\u1eadt.<\/span><\/p>\n V\u00ec s\u1ef1 an to\u00e0n c\u1ee7a b\u00eanh nh\u00e2n, thu\u0309 thu\u00e2\u0323t ti\u00eam c\u1ea7n ph\u1ea3i \u0111\u01b0\u1ee3c th\u1ef1c hi\u1ec7n trong \u0111i\u1ec1u ki\u1ec7n v\u00f4 tr\u00f9ng, do \u0111\u00f3 b\u00ea\u0323nh nh\u00e2n s\u1ebd \u0111\u01b0\u01a1\u0323c ti\u00eam trong ph\u00f2ng m\u1ed5 d\u01b0\u01a1\u0301i g\u00e2y t\u00ea t\u1ea1i ch\u1ed7 b\u1eb1ng thu\u1ed1c nh\u1ecf m\u1eaft. B\u00ea\u0323nh nh\u00e2n s\u1ebd \u0111\u01b0\u1ee3c h\u01b0\u1edbng d\u1eabn nh\u1eadp vi\u1ec7n v\u00e0 \u0111i\u1ec1u tr\u1ecb n\u1ed9i tr\u00fa.<\/span><\/p>\n L\u1ef1a ch\u1ecdn th\u1ef1c hi\u1ec7n th\u1ee7 thu\u1eadt ti\u00eam Lucentis t\u1ea1i b\u1ec7nh vi\u1ec7n M\u1eaft H\u00e0 N\u1ed9i c\u00f3 \u01b0u \u0111i\u1ec3m g\u00ec?<\/span><\/strong><\/p>\n B\u1ec7nh vi\u1ec7n M\u1eaft H\u00e0 N\u1ed9i l\u00e0 \u0111\u1ecba ch\u1ec9 th\u0103m kh\u00e1m, \u0111i\u1ec1u tr\u1ecb c\u00e1c b\u1ec7nh l\u00fd v\u1ec1 m\u1eaft trong \u0111\u00f3 c\u00f3 k\u1ef9 thu\u1eadt ti\u00eam n\u1ed9i nh\u00e3n l\u00e0 k\u1ef9 thu\u1eadt \u0111i\u1ec3n h\u00ecnh \u0111\u01b0\u1ee3c th\u1ef1c hi\u1ec7n th\u01b0\u1eddng xuy\u00ean. Khi th\u1ef1c hi\u1ec7n quy tr\u00ecnh th\u0103m kh\u00e1m t\u1ea1i b\u1ec7nh vi\u1ec7n, kh\u00e1ch h\u00e0ng s\u1ebd \u0111\u01b0\u1ee3c \u0111\u00f3n ti\u1ebfp v\u00e0 s\u1eed d\u1ee5ng c\u01a1 s\u1edf v\u1eadt ch\u1ea5t, h\u1ec7 th\u1ed1ng m\u00e1y m\u00f3c hi\u1ec7n \u0111\u1ea1i \u0111i k\u00e8m v\u1edbi c\u00e1c d\u1ecbch v\u1ee5 y t\u1ebf ho\u00e0n h\u1ea3o, ch\u1ea5t l\u01b0\u1ee3ng \u0111i\u1ec1u tr\u1ecb t\u1ed1t nh\u1ea5t \u0111\u1ebfn t\u1eeb c\u00e1c b\u00e1c s\u0129 chuy\u00ean gia \u0111\u1ea7u ng\u00e0nh.<\/span><\/p>\n Theo \u0111i\u1ec3m k kho\u1ea3n 3 \u0110i\u1ec1u 2 Th\u00f4ng t\u01b0 s\u1ed1 01\/2020\/TT-BYT ng\u00e0y 16\/01\/2020 c\u1ee7a B\u1ed9 Y t\u1ebf quy \u0111\u1ecbnh Thu\u1ed1c Ranibizumab c\u00f3 ch\u1ec9 \u0111\u1ecbnh \u0111\u01b0\u1eddng d\u00f9ng l\u00e0 Ti\u00eam trong d\u1ecbch k\u00ednh t\u1ea1i B\u1ec7nh vi\u1ec7n h\u1ea1ng \u0111\u1eb7c bi\u1ec7t, h\u1ea1ng I v\u1edbi ghi ch\u00fa \u201cQu\u1ef9 BHYT thanh to\u00e1n \u0111i\u1ec1u tr\u1ecb t\u1ea1i khoa m\u1eaft c\u1ee7a c\u00e1c b\u1ec7nh vi\u1ec7n h\u1ea1ng \u0111\u1eb7c bi\u1ec7t; b\u1ec7nh vi\u1ec7n chuy\u00ean khoa m\u1eaft h\u1ea1ng I, II. \u0110i\u1ec1u \u0111\u00f3 c\u00f3 ngh\u0129a l\u00e0, khi b\u1ec7nh nh\u00e2n \u0111i\u1ec1u tr\u1ecb RANIBIZUMAB (LUCENTIS) t\u1ea1i b\u1ec7nh vi\u1ec7n M\u1eaft H\u00e0 N\u1ed9i s\u1ebd \u0111\u01b0\u1ee3c h\u01b0\u1edfng thanh to\u00e1n BHYT cho thu\u1ed1c n\u00e0y theo \u0111\u00fang quy \u0111\u1ecbnh c\u1ee7a BHYT.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":" RANIBIZUMAB (LUCENTIS) l\u00e0 m\u1ed9t lo\u1ea1i thu\u1ed1c kh\u00e1ng VEGF; th\u00e0nh ph\u1ea7n l\u00e0 m\u1ed9t m\u1ea3nh c\u1ee7a kh\u00e1ng th\u1ec3 \u0111\u01a1n d\u00f2ng v\u00e0 \u0111\u00e3 \u0111\u01b0\u1ee3c ch\u1ee9ng nh\u1eadn b\u1edfi C\u1ee5c Qu\u1ea3n l\u00fd Th\u1ef1c ph\u1ea9m v\u00e0 D\u01b0\u1ee3c ph\u1ea9m Hoa K\u1ef3 (FDA) cho \u0111i\u1ec1u tr\u1ecb b\u1ec7nh ph\u00f9 ho\u00e0ng \u0111i\u1ec3m ti\u1ec3u \u0111\u01b0\u1eddng, b\u1ec7nh tho\u00e1i h\u00f3a ho\u00e0ng \u0111i\u1ec3m th\u1ec3 \u01b0\u1edbt, v\u00e0 ph\u00f9 ho\u00e0ng \u0111i\u1ec3m […]<\/p>\n","protected":false},"author":2,"featured_media":2732,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[45,26,123],"tags":[368,366,367,365],"acf":[],"yoast_head":"\n
\nLucentis c\u00f3 c\u00e1c d\u1ea1ng b\u00e0o ch\u1ebf nh\u01b0 sau:<\/span><\/p>\n\n
\n
\n
\n
\n
\n
\n
\n